Try our Advanced Search for more refined results

November 30, 2016

FTC v. Boehringer Ingelheim Pharmace

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. January 06, 2023

    Ahead Of Privilege Arguments, 4 Kavanaugh Rulings To Know

    The U.S. Supreme Court will hear arguments Monday about how to interpret the protection for communications containing both legal and nonlegal topics. But don't expect any overt attempt to convince the court — and particularly Justice Brett Kavanaugh — that a competing "one significant purpose" standard is flat wrong. Here, Law360 Pulse breaks down four significant Justice Kavanaugh decisions dealing with the issue.

2 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!